These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7713204)
1. Longitudinal lung function study in heterozygous PiMZ phenotype subjects. Tarján E; Magyar P; Váczi Z; Lantos A; Vaszár L Eur Respir J; 1994 Dec; 7(12):2199-204. PubMed ID: 7713204 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal decline of diffusing capacity of the lung for carbon monoxide in community subjects with the PiMZ alpha1-antitrypsin phenotype. Silva GE; Guerra S; Keim S; Barbee RA; Sherrill DL Chest; 2008 May; 133(5):1095-100. PubMed ID: 18263681 [TBL] [Abstract][Full Text] [Related]
3. Assessment of alpha-1-antitrypsin deficiency heterozygosity as a risk factor in the etiology of emphysema. Physiological comparison of adult normal and heterozygous protease inhibitor phenotype subjects from a random population. McDonagh DJ; Nathan SP; Knudson RJ; Lebowitz MD J Clin Invest; 1979 Feb; 63(2):299-309. PubMed ID: 311786 [TBL] [Abstract][Full Text] [Related]
4. Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes. Molloy K; Hersh CP; Morris VB; Carroll TP; O'Connor CA; Lasky-Su JA; Greene CM; O'Neill SJ; Silverman EK; McElvaney NG Am J Respir Crit Care Med; 2014 Feb; 189(4):419-27. PubMed ID: 24428606 [TBL] [Abstract][Full Text] [Related]
5. A study on the lung function in alpha 1-antitrypsin-deficient (PiMZ) patients. Kambe M; Morishita K; Tsubokura T; Tsuno K; Kimura T; Utsumi T; Kawamoto H; Yamakido M; Mittman C Hiroshima J Med Sci; 1993 Mar; 42(1):41-5. PubMed ID: 8486520 [TBL] [Abstract][Full Text] [Related]
6. COPD in individuals with the PiMZ alpha-1 antitrypsin genotype. Al Ashry HS; Strange C Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29070580 [TBL] [Abstract][Full Text] [Related]
7. Effects of smoking and intermediate alpha 1-antitrypsin deficiency (PiMZ) on lung function. Eriksson S; Lindell SE; Wiberg R Eur J Respir Dis; 1985 Oct; 67(4):279-85. PubMed ID: 3878302 [TBL] [Abstract][Full Text] [Related]
8. Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups. Foreman MG; Wilson C; DeMeo DL; Hersh CP; Beaty TH; Cho MH; Ziniti J; Curran-Everett D; Criner G; Hokanson JE; Brantly M; Rouhani FN; Sandhaus RA; Crapo JD; Silverman EK; Ann Am Thorac Soc; 2017 Aug; 14(8):1280-1287. PubMed ID: 28380308 [TBL] [Abstract][Full Text] [Related]
9. Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline. Mehta AJ; Thun GA; Imboden M; Ferrarotti I; Keidel D; Künzli N; Kromhout H; Miedinger D; Phuleria H; Rochat T; Russi EW; Schindler C; Schwartz J; Vermeulen R; Luisetti M; Probst-Hensch N; Occup Environ Med; 2014 Apr; 71(4):234-40. PubMed ID: 24213563 [TBL] [Abstract][Full Text] [Related]
10. A longitudinal study of alpha1-antitrypsin phenotypes and decline in FEV1 in a community population. Silva GE; Sherrill DL; Guerra S; Barbee RA Chest; 2003 May; 123(5):1435-40. PubMed ID: 12740258 [TBL] [Abstract][Full Text] [Related]
11. Emphysema due to alpha-antitrypsin deficiency: familial study of the YBARCELONA variant. Miravitlles M; Vilà S; Jardí R; de la Roza C; Rodríguez-Frías F; Vidal R Chest; 2003 Jul; 124(1):404-6. PubMed ID: 12853554 [TBL] [Abstract][Full Text] [Related]
12. Lung distensibility and airway function in intermediate alpha 1-antitrypsin deficiency (Pi MZ). Tattersall SF; Pereira RP; Hunter D; Blundell G; Pride NB Thorax; 1979 Oct; 34(5):637-46. PubMed ID: 316207 [TBL] [Abstract][Full Text] [Related]
13. Risk of hospital admission for obstructive pulmonary disease in alpha(1)-antitrypsin heterozygotes of phenotype PiMZ. Seersholm N; Wilcke JT; Kok-Jensen A; Dirksen A Am J Respir Crit Care Med; 2000 Jan; 161(1):81-4. PubMed ID: 10619801 [TBL] [Abstract][Full Text] [Related]
14. Protease inhibitor phenotype BsaskatoonM is not associated with emphysema - a 20-year follow-up study. Jokic R; Fisher KL; Cockcroft DW Can Respir J; 1999; 6(5):407-11. PubMed ID: 10572206 [TBL] [Abstract][Full Text] [Related]
15. Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates. Silverman EK; Pierce JA; Province MA; Rao DC; Campbell EJ Ann Intern Med; 1989 Dec; 111(12):982-91. PubMed ID: 2596778 [TBL] [Abstract][Full Text] [Related]
16. Α₁-antitrypsin PiMZ heterozygosity has an independent aggravating effect on liver fibrosis in alcoholic liver disease. Goltz D; Hittetiya K; Vössing LM; Kirfel J; Spengler U; Fischer HP Virchows Arch; 2014 Nov; 465(5):539-46. PubMed ID: 25070245 [TBL] [Abstract][Full Text] [Related]
17. SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort. Thun GA; Ferrarotti I; Imboden M; Rochat T; Gerbase M; Kronenberg F; Bridevaux PO; Zemp E; Zorzetto M; Ottaviani S; Russi EW; Luisetti M; Probst-Hensch NM PLoS One; 2012; 7(8):e42728. PubMed ID: 22912729 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary function in nonsmoking subjects with alpha1 antitrypsin deficiency (MZ phenotype). Gelb AF; Klein E; Lieberman J Am J Med; 1977 Jan; 62(1):93-8. PubMed ID: 299981 [TBL] [Abstract][Full Text] [Related]
19. Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects. Malerba M; Ricciardolo F; Radaeli A; Torregiani C; Ceriani L; Mori E; Bontempelli M; Tantucci C; Grassi V Thorax; 2006 Feb; 61(2):129-33. PubMed ID: 16284217 [TBL] [Abstract][Full Text] [Related]
20. Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects. Bruce RM; Cohen BH; Diamond EL; Fallat RJ; Knudson RJ; Lebowitz MD; Mittman C; Patterson CD; Tockman MS Am Rev Respir Dis; 1984 Sep; 130(3):386-90. PubMed ID: 6332562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]